Application 205197
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PLERIXAFOR | PLERIXAFOR | SOLUTION;SUBCUTANEOUS | 24MG/1.2ML (20MG/ML) | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71901 | ORIG | 2022-08-26 |